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Abstract: Age-related macular degeneration (AMD), the leading cause of blindness in the 
elderly, is characterized by the death of photoreceptors and the retinal pigment epithelium (RPE). 
One of the main functions of the RPE is to phagocytose photoreceptor outer segments (POS) 
daily. While lipids in POS are used for energy production in the RPE, this process also produces 
toxic byproducts that cause oxidative damage. This study used induced pluripotent stem cells 
(iPSC) differentiated into RPE from a human donor without AMD (n = 1) to investigate whether 
photoreceptor disease state has an effect on the POS uptake. Results show that POS uptake is not 
dependent on AMD presence, but the uptake is POS donor specific. 
 
1. Introduction 
 Age-related macular degeneration (AMD) is the leading cause of irreversible vision loss 
of the elderly in the developed world [1]. The global prevalence of AMD in 2020 was estimated 
to be 196 million cases and is expected to increase to 288 million by 2040 [2]. AMD causes 
distortion and loss of central vision, leading to blindness [1]. The disease is multifactorial in 
nature, involving a complex interplay between genetic and environmental factors [3]. Although 
there is no cure for AMD, the less common form, “wet” AMD, has treatment options to preserve 
vision including ocular injections to inhibit vascular endothelial growth factor (VEGF), the 
signal for producing more blood vessels [4]. There are currently no effective therapies for the 
more common form of the disease, “dry” AMD, which accounts for approximately 80% of AMD 
2 
 
cases [5]. Dry AMD is characterized by the death of light-sensing photoreceptors and the retinal 
pigment epithelium (RPE). Understanding why these cells die is an important first step for 
developing effective therapies. 
 The RPE is a monolayer of cells that forms the blood-retina barrier and has many 
functions for vision including absorbing light, transporting nutrients to photoreceptors, 
regenerating visual pigments, secreting growth factors to photoreceptors, and phagocytosing 
shed photoreceptor outer segments (POS) [6]. POS must be shed and continually renewed to 
eliminate toxic compounds in photoreceptor membranes and proteins caused by light damage. 
RPE cells are the only cell type to phagocytose daily for their entire life. Phagocytosing more 
material than any other cell type puts the RPE at a high risk for oxidative damage from the toxic 
waste products contained in the POS [7,8]. Phagocytosis of POS by the RPE involves three main 
steps, recognition, internalization, and digestion. RPE recognize phosphatidylserine, an “eat me” 
signal that is exposed on POS tips in a diurnal cycle [9]. Phosphatidylserine is primarily 
recognized by the αvβ5 integrin receptor on RPE cells, which involves additional extracellular 
bridge proteins. Following recognition by αvβ5, POS are internalized via the receptor tyrosine 
kinase Mer (MerTK), through a complex signaling mechanism that allows cytoskeleton and 
plasma membrane rearrangements for POS intake [10]. POS are degraded by phagolysosomes 
containing cathepsin D and S proteases [11]. 
While the mechanism for AMD is still unclear, previous reports from macular 
translocation, a surgical procedure that relocates a section of macular retina to healthy RPE show 
the recurrence of RPE atrophy beneath the relocated macula suggesting the diseased 
photoreceptors could contain molecules that are toxic to RPE [12].  
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In this study, we utilized a cell culture system since it provides a way to compare 
diseased and non-diseased POS in the same RPE. We hypothesize that the RPE will have 
decreased phagocytic uptake when fed diseased POS when compared to feeding of normal POS. 
To our knowledge, isolated human POS from donor eyes that have been graded for the presence 
and severity of AMD have not been used in phagocytosis experiments. 
 
2. Materials and Methods 
2.1 Human Eye Procurement and Grading for AMD 
Donor eyes were obtained from Lions Gift of Sight (St. Paul, MN) and graded for AMD 
severity by a board-certified ophthalmologist (Dr. Sandra Montezuma) using the Minnesota 
Grading System (MGS). MGS 1 represents the control group with no AMD, and MGS 2, 3, and 
4 are early, intermediate, and advanced AMD, respectively [13]. Eyes were obtained with 
consent from the donor family for medical research. 
2.2 Culturing iPSC-RPE Cells 
 The derivation of induced pluripotent stem cell (iPSC) from human conjunctival cells and 
the differentiation into RPE was performed as previously described [14]. iPSC-RPE cells were 
cultured in Minimum Essential Medium Eagle alpha medium (MEMα; Sigma-Aldrich) 
supplemented with Glutamax, 5% FBS, N1 supplement, penicillin, streptomycin, non-essential 
amino acids, taurine, triiodothyronine, and hydrocortisone on 1X Matrigel (Corning) coated 
plates at 37°C, 5% CO2, with two medium changes per week. Cells were dissociated with 
Accumax (Sigma-Aldrich) and passaged to confluency (2x105 cells/cm2). Cells from passages 3-
5 were used in all assays.  
2.3 Purification of POS 
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 The protocol for purification of POS was adapted from Parinot et al., 2014 [15]. POS 
were isolated from retinas of human donor eyes. A 25%-60% sucrose gradient was made in four 
steps by freezing each layer (25%, 36%, 48%, 60% sucrose, 20 mM tris acetate pH 7.2, 10 mM 
glucose, 5 mM taurine) in ice-cold methanol before adding the next, and then stored at -20°C. An 
hour before use, the gradients were thawed at 4°C. Crude retinal homogenates, each containing a 
quarter to half of a retina in homogenization buffer (20% sucrose, 20 mM tris acetate pH 7.2, 2 
mM MgCl2, 10 mM glucose, 5 mM taurine), were made by pulse vortexing at medium speed and 
passaging through a pipette tip with a cut tip. The retinal homogenates were layered on top of the 
sucrose gradient and placed in a centrifuge for one hour at 4°C using a Beckman MLS-50 
Swinging-Bucket rotor at 32,000 rpm (100,000 x g). Purified POS were collected from the 
gradient interface in a single band, washed sequentially with wash 1 (20 mM tris acetate pH 7.2, 
5 mM taurine), wash 2 (10% sucrose, 20 mM tris acetate pH 7.2, 5 mM taurine), wash 3 (10% 
sucrose, 20 mM sodium phosphate pH 7.2, 5 mM taurine), and counted using a hemocytometer 
as described in Parinot et al., 2014 [15]. Purified POS were stored in aliquots of 10 million POS 
at -80°C in MEMα media containing 2.5% sucrose. 
2.4 POS Phagocytosis 
 Purified POS were labeled with FITC (fluorescein isothiocyanate isomer I; 
ThermoFisher), a fluorescent probe that labels amine groups. The solid FITC was reconstituted 
to 2.5 mg/mL in a sodium bicarbonate buffer (0.1 M sodium carbonate pH 9.5) by mixing for 1 
hour while protected from light. After reconstitution, the POS pellet, containing approximately 
10 million POS, was incubated for 1.5 hours while protected from light. Following the FITC 
incubation, labeled POS were washed using wash 3 (as described above) and resuspended in 
MEMα media as described in Parinot et al., 2014 [15]. The labeled POS were added to 
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confluent, adherent iPSC-RPE in a 48-well plate at a concentration of 10 POS/cell. The POS 
were incubated at 37°C, 5% CO2 with the cells for different amounts of time. After incubation, 
cells were washed with Dulbecco’s phosphate buffered saline (DPBS; ThermoFisher) containing 
Ca and Mg, then single cells were collected using Accumax. The cells were washed with DPBS 
without Ca and Mg and resuspended in 1% BSA in DPBS. Both bright field and fluorescent 
images were taken at 20x magnification using a Cytation 1 (BioTek) and Gen5 software 
(BioTek). Images were prepared using Fiji (ImageJ). Fluorescence-activated cell sorting (FACS) 
was performed using a BD LSRFortessa and the data was analyzed with FlowJo software. 
2.5 Western Blotting 
 Membrane proteins from purified POS were solubilized using 30mM octylglucoside, 
10mM tris acetate, and 5mM MgCl2 pH 7.2. Following FACS analysis, cell pellets were 
collected and lysed in RIPA buffer. Protein concentrations were determined with the 
Bicinchoninic acid assay, using albumin as the standard. Proteins were resolved by SDS-PAGE 
on polyacrylamide gels made with 2,2,2-Trichloroethanol that when UV light activated allowed 
for visualization of protein. Proteins were transferred to low-fluorescence Polyvinylidene 
difluoride (PVDF) membranes using BioRad Turbo Blot, then imaged to normalize to protein 
load. Membranes were incubated overnight with a primary antibody, Rhodopsin (Abcam 
ab5417). Secondary antibodies conjugated to horseradish peroxidase along with the 
Chemiluminescence kit (ThermoFisher) were used to visualize the immune reactions. Images 
were taken using a BioRad ChemiDoc XRS. Densitometry was performed using Image Lab 
software (BioRad). Intensity of bands were normalized for protein load and to a standard run on 
each blot. 
2.6 Statistical Analysis 
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 Linear regression and t-tests were performed using GraphPad Prism 9 (GraphPad 
Software). p ≤ 0.05 was considered statistically significant. 
 
3. Results 
3.1 Donor Demographics 
 The somatic cell source for the iPSC-RPE in this study were epithelial cells from the 
conjunctiva of human donor eyes. POS were isolated from human donor retinal tissue. Donor 
demographics and clinical information from the Lions Gift of Sight for iPSC-RPE generation 
and POS isolation used in this study is summarized in Table 1. The presence and severity of 
AMD was determined with high resolution retinal photomicrographs using the MGS [13]. 
Donors included those with no AMD (MGS1) and AMD (MGS2). The average age of donors 
used for POS isolation with no AMD (74 ± 10.3 years) and AMD (77 ± 2.5 years) is not 
significantly different (p = 0.83) by t-test comparison. 
Table 1. Donor characteristics. aAge of donor in years. bGender of donor. M = male, F = 
female. cMGS was used to evaluate the stage of AMD. MGS 1 = no disease, MGS 2 = early 
disease. dTime of death in military time. 
Donor ID Agea/Genderb MGS 
Stagec 





80/M 1 Brain hemorrhage 21:02 Generation of 
iPSC-RPE 
MGS1-0746 66/M 1 Cardiovascular 
collapse 
1:01 POS isolation 
MGS1-0949 82/F 1 Anoxic brain injury 18:50 POS isolation 
MGS2-0833 83/F 2 Brain aneurysm 16:45 POS isolation 
MGS2-0871 70/F 2 Natural 18:50 POS isolation 
3.2 Characterization of POS 
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 POS were isolated from human donor retinas using a sucrose gradient as described.  
Following centrifugation, a single band containing purified POS was obtained from the gradient 
interface at ~48% (Figure 1A). Preliminary characterization of POS was needed to ensure the 
quality of the preparation. Purified POS were imaged to calculate yield and analyze quality 
(Figure 1B, 1C). Our POS preparations exhibited both elongated and whirled forms (Figure 1B) 
[15]. The average POS yield per retina was 16.3 x 106 ± 3.3 x 106.  
 
Figure 1. POS isolation. (A) Sucrose gradient from 25-60% containing the purified POS band 
around 48% sucrose. (B) Purified POS in trypan blue under 20X magnification. POS may be 
observed as elongated (red arrow) or whirled (yellow arrow) forms. (C) Purified POS under 60X 
magnification. Scale bar = 20µm. (D) Image of western blot showing rhodopsin content in 
purified POS. Rhodopsin bands (RHO) were normalized to stain free image of protein load. 
 To further characterize POS, disc membranes were disrupted with octylglucoside and 
rhodopsin content was analyzed via western blotting. Prior to detecting rhodopsin, a stain free 
image of the blot was taken to analyze all protein content of the POS preparation. Our 
preparation shows that the POS have multiple proteins, but rhodopsin is the major component 
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(Figure 1D). After detection of rhodopsin, abundant content was observed in our preparation of 
POS (Figure 1D). Multiple bands were observed, representing rhodopsin monomers, dimers, and 
trimers [16].  
3.3 Phagocytosis of POS 
iPSC-RPE were incubated with 10 FITC-labeled POS/cell from 1-6 hours to determine 
optimal timing for uptake. An additional overnight time point was used to get an estimate of the 
total number of RPE that phagocytose POS. Immediately before collecting single cells for 
FACS, bright field and fluorescent images were taken to ensure POS uptake by the iPSC-RPE 
(Figure 2A). FACS analysis was performed on single cells following POS incubation, and the 
percentage of cells containing FITC-labeled POS was determined (Figure 2B, 2C). The linear 
range of POS uptake was observed from 0-2 hours, with a plateau of uptake around 4 hours. The 
linear range of uptake was chosen to compare the effect of disease on phagocytosis. Following 





Figure 2. Functional analysis of POS. (A) Images of confluent iPSC-RPE without POS (NT) 
and after overnight incubation (O/N). (B) Graph showing preliminary FACS data from three 
different experiments. (C) Scatterplot from FACS of iPSC-RPE with and without POS. Upper 
right quadrant indicates percentage of RPE with internalized FITC-labeled POS. NT = no POS 
treatment, O/N = overnight POS treatment. 
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3.4 No Significant Difference in AMD POS Uptake 
To determine if there are disease-dependent differences in the rates of POS uptake, we 
utilized the linear range of uptake from 0-2 hours. POS isolated from donors with (n = 2) and 
without (n = 2) AMD were fed to iPSC-RPE from the same donor for 0.75, 1.5, and 2.25 hours. 
Linear models were used to determine the rate because the slopes fit the data based on the R2 
values (Figure 3).  
Comparison of diseased and non-diseased POS uptake was not significant; the uptake 
slope of POS without AMD was 5.214, while the AMD POS uptake slope was 6.937 (p = 
0.3292) (Figure 3A). However, when comparing each POS donor separately, the slopes 
significantly differ from each other, because there is no overlap in the 95% confidence intervals 
(Figure 3B). Results indicate that uptake is dependent on the POS donor rather than the presence 
of AMD (Figure 3B). 
 
Figure 3. Uptake of POS by iPSC-RPE. (A) Average uptake of no AMD and AMD POS. Data 
is presented as mean ± SEM. (B) Comparison of uptake for each individual POS donor. Data is 
presented as a single measurement of each sample. Tables summarize slope and R squared 
values. Dotted lines represent 95% confidence intervals. 
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 To monitor rhodopsin degradation after phagocytosis, this experiment analyzed the 
rhodopsin C-terminus presence and disappearance. Previous work has established that the C-
terminus of rhodopsin is degraded first in the RPE [17]. Following FACS analysis, the POS 
treated cells were collected and lysed for western blot analysis of rhodopsin (C-terminus) (Figure 
4A). The content of the C-terminus of rhodopsin generally decreases over time (Figure 4B). 
When comparing rhodopsin content between AMD and no AMD POS treatment, the only 
statistically significant difference was observed at 1.5h.  
 
Figure 4. Western blot analysis of rhodopsin. (A) Representative image of western blots used 
to analyze rhodopsin content of iPSC-RPE after POS treatment and FACS analysis. Stain free 
image was used to normalize to protein load. (B) Average relative density of rhodopsin 
12 
 
(monomer and dimer) relative to no AMD 0.75h. An unpaired t-test was used to compare disease 
status. Data is presented as mean ± SEM. * p < 0.05 determined by unpaired t-tests comparing 
disease vs no disease. NT = no POS treatment. 
 
4. Discussion 
 In this study, we used purified POS isolated from human donors graded for the presence 
and severity of AMD. This model system allowed comparison of the feeding of diseased or non-
diseased POS to iPSC-RPE cells in culture. Our results show that there is no significant 
difference in the uptake of AMD vs no AMD POS by iPSC-RPE (Figure 3A). However, there is 
a significant difference in the phagocytosis rate of each individual POS donor (Figure 3B). 
Rhodopsin content after FACS analysis showed that the POS were being degraded by the RPE 
over time (Figure 4).  
 The difference in individual donor POS uptake may relate to the complex mechanism of 
phagocytosis. The key molecule present in POS, phosphatidylserine, is exposed on the POS tips 
in a diurnal rhythm, suggesting the time of death of the donor may affect how well the iPSC-RPE 
can recognize and internalize the POS [9]. For example, MGS1-0746 had the lowest uptake slope 
with the time of death at 1am. The other three POS donors had a time of death in the early 
evening, with uptake averaging about 2-fold faster. A future direction for this study would be to 
analyze the phosphatidylserine content by mass spectroscopy in our POS preparations and 
analyze if the time of death is a factor in our phagocytosis experiments.  
 Analysis of POS uptake based on FACS shows no difference based on disease state of the 
POS donor. However, analysis of rhodopsin content after POS treatments showed a significant 
difference between AMD and no AMD POS treatment at 1.5h. This significant difference in 
13 
 
rhodopsin content suggests degradation of POS could be disease dependent. However, these 
results reflect the competing actions of uptake and degradation, so additional experiments may 
have to be utilized to uncover other mechanisms involved. Future studies will continue to 
investigate the degradation of POS and the effect of disease status. 
 The limitations of this study include the low number of samples and variable time of 
death of the donors, which could have affected the uptake of POS. This study also used one 
iPSC-RPE donor without AMD, so the disease state of RPE with the same POS was not 
compared. Previous studies on AMD RPE have shown decreased mitochondrial function and 
dysfunctional autophagy, which are both connected to phagocytosis [18,19]. Disease state of 
RPE may also alter the uptake and degradation of POS.  
 In summary, our results show that there is no difference in POS uptake by iPSC-RPE 
when comparing disease status of POS. When comparing individual donors, rates of 
phagocytosis are significantly different. Analysis of rhodopsin content in cells after POS 
treatment shows a significant difference between AMD and no AMD at 1.5h. These results 
suggest factors other than disease, such as phosphatidylserine content of POS, could influence 
the uptake.  
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